The association of rate pressure product (RPP) and myocardial perfusion imaging (MPI) findings: A preliminary study

Perfusion

Volumn 27, Issue 3, 2012, Pages 207-213

  Ansari, M ^a   Javadi, H ^b   Pourbehi, M ^c   Mogharrabi, M ^d   Rayzan, M ^c   Semnani, S ^b   Jallalat, S ^b   Amini, A ^c   Abbaszadeh, M ^c   Barekat, M ^c   Nabipour, I ^c   Assadi, M ^c  

^a SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c BUSHEHR UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d GOLESTAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

blood pressure (BP); coronary artery disease (CAD); heart rate (HR); myocardial perfusion imaging (MPI); rate pressure product (RPP)

Indexed keywords

DIPYRIDAMOLE;

ADULT; ARTERIAL PRESSURE; ARTICLE; CARDIOVASCULAR PARAMETERS; CLINICAL PRACTICE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIASTOLIC BLOOD PRESSURE; ELECTROCARDIOGRAPHY; EXERCISE TEST; FEMALE; HEART RATE; HUMAN; MAJOR CLINICAL STUDY; MALE; MYOCARDIAL PERFUSION IMAGING; PRIORITY JOURNAL; RATE PRESSURE PRODUCT; RISK FACTOR; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STRESS; SYSTOLIC BLOOD PRESSURE;

AGED; ANGINA PECTORIS; BLOOD PRESSURE; CARDIAC-GATED SINGLE-PHOTON EMISSION COMPUTER-ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; ELECTROCARDIOGRAPHY; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MALE; MIDDLE AGED; MYOCARDIAL PERFUSION IMAGING; RISK FACTORS;

EID: 84860451334     PISSN: 02676591     EISSN: 1477111X     Source Type: Journal    
DOI: 10.1177/0267659112436631     Document Type: Article

References (25)

1. Nagpal S, Walia L, Lata H, Sood N, Ahuja GK. Effect of exercise on rate pressure product in premenopausal and postmenopausal women with coronary artery disease. Indian J Physiol Pharmacol. 2007 ; 51 (3). 279-283
2. Frank SM, Satitpunwaycha P, Bruce SR, Herscovitch P, Goldstein DS. Increased myocardial perfusion and sympathoadrenal activation during mild core hypothermia in awake humans. Clin Sci (Lond). 2003 ; 104 (5). 503-508
3. Arya A, Maleki M, Noohi F, Kassaian E, Roshanali F. Myocardial oxygen consumption index in patients with coronary artery disease. Asian Cardiovasc Thorac Ann. 2005 ; 13 (1). 34-37
4. Kronenberg MW, Cohen GI, Leonen MF, Mladsi TA, Di Carli MF. Myocardial oxidative metabolic supply-demand relationships in patients with nonischemic dilated cardiomyopathy. J Nucl Cardiol. 2006 ; 13 (4). 544-553
5. Wilkinson PL, Moyers JR, Ports T, Chatterjee K, Ullyott D, Hamilton WK. Rate-pressure product and myocardial oxygen consumption during surgery for coronary artery bypass. Circulation. 1979 ; 60 (2 Pt 2). 170-173
6. Kal JE, Van Wezel HB, Vergroesen I. A critical appraisal of the rate pressure product as index of myocardial oxygen consumption for the study of metabolic coronary flow regulation. Int J Cardiol. 1999 ; 71 (2). 141-148
7. Nelson RR, Gobel FL, Jorgensen CR, Wang K, Wang Y, Taylor HL. Hemodynamic predictors of myocardial oxygen consumption during static and dynamic exercise. Circulation. 1974 ; 50 (6). 1179-1189
8. Mamede M, Tadamura E, Hosokawa R, et al. Comparison of myocardial blood flow induced by adenosine triphosphate and dipyridamole in patients with coronary artery disease. Ann Nucl Med. 2005 ; 19 (8). 711-717
9. Miller DR, Martineau RJ. Bolus administration of esmolol for the treatment of intraoperative myocardial ischaemia. Can J Anaesth. 1989 ; 36 (5). 593-597
10. Zargar JA, Naqash IA, Gurcoo SA, Din MU. Comparative evaluation of the effect of metoprolol and esmolol on rate pressure product and ECG changes during laryngoscopy and endotracheal intubation in controlled hypertensive patients. Indian J Anaesth. 2002 ; 46 (5). 363-368
11. May GA, Nagle FJ. Changes in rate-pressure product with physical training of individuals with coronary artery disease. Phys Ther. 1984 ; 64 (9). 1361-1366
12. Forjaz CL, Matsudaira Y, Rodrigues FB, Nunes N, Negrao CE. Post-exercise changes in blood pressure, heart rate and rate pressure product at different exercise intensities in normotensive humans. Braz J Med Biol Res. 1998 ; 31 (10). 1247-1255
13. Govindaraju M, Mital A. Myocardial oxygen increases due to physical training in individuals with coronary heart disease (CHD): rate pressure product (RPP) measurements. J Occup Rehabil. 1997 ; 7 (3). 173-183
14. White WB. Heart rate and the rate-pressure product as determinants of cardiovascular risk in patients with hypertension. Am J Hypertens. 1999 ; 12 (2 Pt 2). 50S - 55S
15. 1996 National Heart Foundation clinical guidelines for the assessment and management of dyslipidaemia. N Z Med J. 1996 ; 109 (1024). 224-231
16. Javadi H, Shariati M, Mogharrabi M, et al. The association of dipyridamole side effects with hemodynamic parameters, ECG findings, and scintigraphy outcomes. J Nucl Med Technol. 2010 ; 38 (3). 149-152
17. Johnston DL, Daley JR, Hodge DO, Hopfenspirger MR, Gibbons RJ. Hemodynamic responses and adverse effects associated with adenosine and dipyridamole pharmacologic stress testing: a comparison in 2,000 patients. Mayo Clin Proc. 1995 ; 70 (4). 331-336
18. Coelho EM, Monteiro F, Da Conceicao JM, et al. The rate pressure product: fact of fallacy?. Angiology. 1982 ; 33 (10). 685-689
19. Robinson BF. Relation of heart rate and systolic blood pressure to the onset of pain in angina pectoris. Circulation. 1967 ; 35 (6). 1073-1083
20. Agostini D, Iida H, Takahashi A, Tamura Y, Henry Amar M, Ono Y. Regional myocardial metabolic rate of oxygen measured by O2-15 inhalation and positron emission tomography in patients with cardiomyopathy. Clin Nucl Med. 2001 ; 26 (1). 41-49
21. Hattori N, Tamaki N, Kudoh T, et al. Abnormality of myocardial oxidative metabolism in noninsulin-dependent diabetes mellitus. J Nucl Med. 1998 ; 39 (11). 1835-1840
22. Tamaki N, Magata Y, Takahashi N, et al. Oxidative metabolism in the myocardium in normal subjects during dobutamine infusion. Eur J Nucl Med. 1993 ; 20 (3). 231-237
23. Henes CG, Bergmann SR, Walsh MN, Sobel BE, Geltman EM. Assessment of myocardial oxidative metabolic reserve with positron emission tomography and carbon-11 acetate. J Nucl Med. 1989 ; 30 (9). 1489-1499
24. Seki M, Mizushige K, Ueda T, Kitadai M, Matsuo H. Effect of olprinone, a phosphodiesterase III inhibitor, on arterial wall distensibility: differentiation between aorta and common carotid artery. Heart Vessels. 1999 ; 14 (5). 224-231
25. Rosenson RS, Wolff D, Green D, Boss AH, Kensey KR. Aspirin. Aspirin does not alter native blood viscosity. J Thromb Haemost. 2004 ; 2 (2). 340-341